Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 4 April 2008:
Vol. 320. no. 5872, pp. 53 - 54
DOI: 10.1126/science.1156604
Prev | Table of Contents | Next

Policy Forum

PUBLIC HEALTH:
A Case Study of Personalized Medicine

S. H. Katsanis, G. Javitt, K. Hudson,*

Marketing of unproven tests shows the need for regulatory action to protect public health.

Genetics and Public Policy Center, the Johns Hopkins University, Washington, DC 20036, USA

*Author for correspondence. E-mail: khudson5{at}jhu.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Genetic Risk Prediction -- Are We There Yet?.
P. Kraft and D. J. Hunter (2009)
N. Engl. J. Med. 360, 1701-1703
   Full Text »    PDF »
Regulatory Agency Consideration of Pharmacogenomics.
M. K. Pendergast (2008)
Experimental Biology and Medicine 233, 1498-1503
   Abstract »    Full Text »    PDF »
The Health Benefits Of Genomics: Out With The Old, In With The New.
K. Hudson (2008)
Health Aff. 27, 1612-1615
   Abstract »    Full Text »    PDF »
The regulation of direct-to-consumer genetic tests.
J. Kaye (2008)
Hum. Mol. Genet. 17, R180-R183
   Abstract »    Full Text »    PDF »
Reviews of Note.
(2008)
Journal Watch Psychiatry 2008, 1
   Full Text »

E-Letters:

Read all E-Letters

Global Direct-to-Consumer Marketing Strategies Call for Global Oversight
David Gurwitz, et al.
Science Online, 3 Oct 2008 [Full text]
Promises, Promises
Neil A. Holtzman
Science Online, 3 Oct 2008 [Full text]
Assessing Drug Metabolism
Laura Lowe Furge
Science Online, 3 Oct 2008 [Full text]

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)